RxDoctor Payments Data

Mark Logan, PA

Physician Assistant · Anchorage, AKNPI 1508994104

Payments from drug & device makers

$807in general payments, 2019–2025

Across 36 payments — averaging $22.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$116
  • Astellas Pharma Global Development$110
  • Sumitomo Pharma America, Inc.$77
  • Novartis$54
  • Urogen Pharma, Inc.$48
  • Bayer$42
  • plus $361 from 15 others

What the payments were for

  • Food & beverage$69786%
  • Education$11014%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$807 in reported general payments places this provider in the 80th percentile of 365 physician assistant providers in Alaska.

See all physician assistant providers in Alaska

Medicare billing

Part B allowed, 2024
$22,529
Medicare patients
168
Services billed
346

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron49$32,115
MyrbetriqMirabegron17$9,113
Tamsulosin Hcl189$1,834
Methenamine Hippurate24$1,106
Finasteride86$795
Estradiol16$792
Solifenacin Succinate21$504
Alfuzosin Hcl ErAlfuzosin Hcl21$308
Doxycycline Hyclate34$188
Oxybutynin Chloride ErOxybutynin Chloride14$98
Cephalexin16$67

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$77$32,11549 claims
Astellas Pharma US IncMyrbetriq$116$9,11317 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 365 physician assistant providers in Alaska.

Other physician assistant in Anchorage

See the full list for Alaska

Where these figures come from

Is this you, or does something look wrong? →